Results 101 to 110 of about 20,626 (231)

Exacerbated Hepatic Stress and Systemic Metabolic Disruption Driven by SARS‐CoV‐2 P.1 Variant in K18‐hACE2 Mice

Immunity, Inflammation and Disease, Volume 14, Issue 6, June 2026.
ABSTRACT Introduction While severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been extensively studied in the context of pulmonary disease, its impact on metabolic organs remains poorly understood, particularly across experimental models.
Monara Kaélle Sérvulo Cruz Angelim, Patrícia Brito Rodrigues, Antônio Thiago Pereira Campos, Giovanni Freitas Gome, Gabriela Fabiano Souza, Valquíria Aparecida Matheus, Carlos Lenz Cesar, José Luiz Proença‐Módena, Marco Aurélio R. Vinolo, Pedro M. Moraes‐Vieira   +9 more
wiley   +1 more source

Cumulative incidence of ketosis in fresh lactating cows: a case study in the United Arab Emirates

BMC Veterinary Research
Non-infectious diseases such as ketosis could present a major threat to the development of the dairy subsector in the United Arab Emirates (UAE). A retrospective study (2019 to 2022) was conducted on 7511 fresh lactating cows to estimate the monthly ...
Gobena Ameni, Shaikha Saif Ali Alshamsi, Berecha Bayissa, Aboma Zewude, Temesgen Mohammed, Berhanu Adnew Degefa, Mansour Alhemairi, Asha Antony, Khaja Mohteshamuddin, Gopala Kalaiah, Mohammed Ali Omer, Meera Saeed Alkalbani, Yassir Mohammed Eltahir, Mohamed Elfatih Hamad, Ihab Habib, Teshale Sori, Markos Tibbo   +16 more
doaj   +1 more source

Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic Responses

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Sodium glucose cotransporter‐2 (SGLT2) inhibitors are a class of antidiabetics with benefits including HbA1c‐lowering, weight loss, cardiovascular and renal protection in addition to adverse effects including genitourinary tract infections, ketoacidosis, and bone loss.
May E. Montasser, Salma A. Bargal, Elizabeth A. Streeten, Hilary B. Whitlatch, Zhinous Shahidzadeh Yazdi, Jordin Sirody, Rosanna Kiplagat, Merna Beshara, Jeffrey R. O’Connell, Simeon I. Taylor, Amber L. Beitelshees   +10 more
wiley   +1 more source

Development and Validation of a Risk Prediction Model for Ketosis-Prone Type 2 Diabetes Mellitus Among Patients Newly Diagnosed with Type 2 Diabetes Mellitus in China

, 2023
Yanjuan Jiang,1 Jianting Zhu,2 Xiaoyang Lai1 1Department of Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2Department of Intensive Care Unit, The Second Affiliated Hospital of Nanchang ...
Jiang Y, Lai X, Zhu J
core  

Clinically significant hypoglycaemia in hospitalised adults: A multicentre study of 1205 episodes in the United Kingdom

Diabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Introduction and Objectives Inpatient hypoglycaemia is a serious complication of diabetes therapy, yet real‐world data on clinically significant episodes remain limited. The objectives of this study are (1) to describe the clinical and biochemical characteristics of clinically significant inpatient hypoglycaemia across multiple NHS sites, (2 ...
Charles Page, Mariam Idrissi, Sam Sherratt‐Mayhew, Aashritha Buchipudi, Amanda Ling Jie Yee, Kalyaani Persad, Aqeelah Khatoon, Amrit Rakkar, Amynta Arshad, Alexandra Lubina Solomon, Rajeev Raghavan, Lakshmi Rengarajan, Ahmed Iqbal, Pratik Choudhary, Aspasia Manta, Punith Kempegowda, DEVI Collaboration   +16 more
wiley   +1 more source

New Ketosis Test Developed

, 1963
A test for ketosis that is two to three times more sensitive than any field test on the market today has been developed by Michigan State University scientists.

core  

Studies in the Ketosis of Fasting* [PDF]

Journal of Clinical Investigation, 1967
A series of experiments was performed during the induction of starvation ketosis and in the acute reversal of the ketotic state. In contrast to the predictions of two widely held theories of ketogenesis, control of acetoacetate production by the liver appeared to be unrelated to changes in fatty acid mobilization from the periphery, fatty acid ...
openaire   +2 more sources

Interrelationship Between Baseline HbA1c, SGLT‐2 Inhibitor Use and Risk of Diabetic Ketoacidosis in Adults With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5217-5228, June 2026.
ABSTRACT Aims There is ongoing uncertainty about whether initiating sodium–glucose co‐transporter 2 inhibitor (SGLT‐2i) therapy in individuals with type 2 diabetes (T2D) who have elevated baseline HbA1c levels may lead to an additive or potentially synergistic increase in the risk of diabetic ketoacidosis (DKA). This systematic review and meta‐analysis
Samuel Seidu, Setor K. Kunutsor, Erwin Taguiam, Kamlesh Khunti   +3 more
wiley   +1 more source

Failure of Urine Dipsticks to Detect Ketosis in Rats [PDF]

, 2011
Bielohuby, Maximilian, Bidlingmaier, Martin, Maximilian Bielohuby, Martin Bidlingmaier, Menhofer, Dominik, Barbara J.M. Stoehr, Stoehr, Barbara J. M., Dominik Menhofer   +7 more
core   +1 more source

Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase.

, 2002
Inappropriate production of nitric oxide (NO) may be responsible for the haemodynamic disturbances of diabetic ketoacidosis. We investigated whether this metabolic condition is associated with increased plasma nitrate (the stable oxidation product of NO)
PENGO, VITTORIO, Iori E, S. V. De Kreutzenberg, E. Iori, Milani M, AVOGARO, ANGELO, A. Avogaro, V. Pengo, TIENGO, ANTONIO, A. Tiengo, CALO', LORENZO, Valbusa D, CEOLOTTO, GIULIO, VIGILI DE KREUTZENBERG, SAULA, L. Calò, G. Ceolotto, M. Milani, D. Valbusa   +17 more
core   +1 more source